Navigation Links
Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
Date:2/14/2008

Three-Year Extension for Integrated Drug Discovery Support in the Search of

Novel Drug Candidates for the Treatment of Huntington Disease

HAMBURG, Germany, OXFORD, England and LOS ANGELES, California, February 14 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that CHDI Foundation, Inc., a not-for-profit organization pursuing a biotech approach to finding therapies for Huntington Disease (HD), has extended its collaboration with Evotec to the end of 2010 to help them advance their Huntington's Disease drug discovery programs. This contract extension is worth up to US$ 37 million in research payments for Evotec.

The collaboration covers Evotec's entire drug discovery offering, including its expertise in medicinal chemistry, biology and compound sourcing. Specifically, this includes biochemical and cellular assay development and high content screening on interesting cell lines with the aim of identifying novel starting points for medicinal chemistry programs. In addition, Evotec supplies key support in the area of medicinal chemistry and supporting biology optimization on multiple biological targets that are of high importance for the treatment of HD. Using skills in computational chemistry, structural biology and protein crystallography, Evotec characterizes active compounds further and optimizes their potency and selectivity to generate lead molecules for subsequent progression into clinical trials.

Evotec and CHDI have worked together since March 2006. During this time, the collaborative relationship has grown significantly. In addition to the contract extension announced today, the companies also have an agreement whereby Evotec provides ultra-high-throughput screening (uHTS) support.

"This is an important collaboration for CHDI. As collaborative enablers, CHDI depends on a network of academic and industrial partners to conduct its research efforts. Based on 18 months of working together s
'/>"/>

SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
2. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
3. Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York
4. Evotec AG: R&D Update on 16 October 2007 Live on the Internet
5. Evotec Reports Third Quarter 2007 Results
6. Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board
7. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
8. Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
9. Roche Extends Tender Offer for Ventana
10. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
11. NASA Extends Cooperative Agreement With NSBRI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Ambassador to also Visit Detroit , ...avid Appia, French Ambassador for International In...ance Agency, , , , ,What: Ambassador Appia is ava...siness initiatives adopted by France to further de... for innovation and development., , ,When: Availab...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fir...oday announced that it has received notice from,th...s common stock will be,suspended as of November 30...curities and Exchange Commission, which will remov...less the company files an appeal to the Nasdaq,Lis...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutical...ice (PTO) has allowed the patent application for,i..., NOD technology is a highly efficient ap...o-adhesive nano-particles to enable oral delivery ... technology is a platform technology,that can be a...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...N.C., Nov. 5 As biopharmaceutical,companies conti... efforts,are placed on strategy and execution from...luations largely focus on revenue growth and littl...launch excellence, a recent study,was conducted by...ith,insights available in the newly published repo...
...-DAC(TM):Exendin-4 Data in December - - PC-Insuli...RNewswire-FirstCall/ - ConjuChem Biotechnologies,I...ete for its Phase II,clinical trial of PC-DAC(TM):...ouble-blind, placebo-controlled, multiple dose stu... months of weekly injections of,PC-DAC(TM):Exendin...
...., Nov. 5 BioMarin,Pharmaceutical Inc. (Nasdaq: ... Chief Executive Officer of BioMarin, will present... Healthcare Conference in Phoenix,Arizona on Wedne...ested parties may access a live audio webcast of t... BioMarin website, http://www.BMRN.com .,A replay...
Other Biology Technology:New Study Provides Key Findings for Biopharma Product Launch Evaluation 2ConjuChem Provides Development Update 2ConjuChem Provides Development Update 3BioMarin to Present at the Credit Suisse Healthcare Conference 2
(Date:11/26/2009)...resistant Staphylococcus Aureus ) and other drug-...temperature plasma prototype devices have been dev...ctericidal cocktails. , Two prototype devices ha...of healthy skin (e.g. hands and feet) in hospitals...l threat; and another to shoot bacteria-killing ag...
(Date:11/25/2009)...irefighters, police officers and ambulance workers...de Center complex. They battled to save people fro...rs, tackled fires and evacuated as many people as ... 17,000 people. And making their jobs even harder ... workers and their relatives jammed mobile network...
(Date:11/25/2009)...versity assistant professors recently received fun... continue research beneficial to understanding the... Christopher Blackwood, assistant professor in the...ants to support two separate research projects. ,...omposer Communities and Functions from the Leaf to...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2FiLife Announces New Twitter Contest on Fixing the American Healthcare System 56561 1FiLife Announces New Twitter Contest on Fixing the American Healthcare System 56561 2Obesity Driving Americas Healthcare to a Tipping Point 56556 1Obesity Driving Americas Healthcare to a Tipping Point 56556 2Obesity Driving Americas Healthcare to a Tipping Point 56556 3Obesity Driving Americas Healthcare to a Tipping Point 56556 4Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP 1 Analog 13938 1Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP 1 Analog 13938 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP 1 Analog 13938 3
...ffering chronic obstructive pulmonary disease (COP... finding that contradicts the conventional wisdom ... "Evidence for attempted regional elastic fiber re..., Kristin Castillo, Alexander Patterson and Richar... Joel Cooper of the University of Pennsylvania, Ph...
...ring researchers at UC San Diego report in the Nov...changes in a bacterial genome, observed in near-re...y published static "snapshots" of the genome seque...harmless to those that cause plague, but this new ... , "Paleontologists look at the fossil record to s...
...rsity Medical Center have visualized in a living a...to dice and splice genetic material to create uniq...indings, made in mice, help explain a key wonder o... cell of an individual’s body can produce differen...varied proteins, in turn, dictate the function of ...
Other Biology News:Lungs try to repair damaged elastic fibers 2Novel experiment documents evolution of genome in near-real time 2Novel experiment documents evolution of genome in near-real time 3Living view in animals shows how cells decide to make proteins 2Living view in animals shows how cells decide to make proteins 3
Product Information Request - U-0080D Diode Array Bio-Spectrophotometer from Hitachi High Technologies America
...izers are available in two product models - the 50...o models is that the 6000AT+ includes a membrane d...rosol for improved detection limits and reduced ox...limits for a range of elements by 10-40 times. Not...
...5%NEN Radiolabeled Ligands\n\nReceptor-related res...ability of new radiolabeled ligands selected to ke... wide range of products and services for receptor ...ate-of-the-art radioligands. If you do not find ex...
AMV RT HC 600 U from Invitrogen
Biology Products: